Advanced search
Publication Cover
Platelets Volume 31, 2020 - Issue 2
Submit an article Journal homepage
353
Views
4
CrossRef citations to date
0
Altmetric
Reviews

Inhibition of platelet activation using vitamins

Gennadi KobzarDepartment of Chemistry and Biotechnology, Tallinn University of Technology, Tallinn, EstoniaCorrespondence[email protected]
View further author information
Pages 157-166 | Received 26 Mar 2019, Accepted 24 Jul 2019, Published online: 19 Aug 2019

  • Rajendran P, Rengarajan T, Thangavel J, Nishigaki Y, Sakthisekaran D, Sethi G, Nishigaki I. The vascular endothelium and human diseases. Int J Biol Sci 2013;9(10):1057–1069. doi:10.7150/ijbs.7502. PMCID: PMC3831119.
  • Fuentes QE, Fuentes QF, Andrés V, Pello OM, Font de Mora J, Palomo GI. Role of platelets as mediators that link inflammation and thrombosis in atherosclerosis. Platelets 2013;24(4):255–262. doi:10.3109/09537104.2012.690113. PMID: 22671308.
  • Tang G-Y, Meng X, Li Y, Zhao C-N, Liu Q, Li H-B. Effects of vegetables on cardiovascular diseases and related mechanisms. Nutrients 2017;9(8):857. doi:10.3390/nu9080857. PMID: 28796173.
  • Torres-Urrutia C, Guzmán L, Schmeda-Hirschmann G, Moore-Carrasco R, Alarcón M, Astudillo L, Gutierrez M, Carrasco G, Yuri JA, Aranda E, et al. Antiplatelet, anticoagulant, and fibrinolytic activity in vitro of extracts from selected fruits and vegetables. Blood Coagul Fibrinolysis 2011;22(3):197–205. doi:10.1097/MBC.0b013e328343f7da. PMID:21311321.
  • Ghoshal K, Bhattacharyya M. Overview of platelet physiology: its hemostatic and nonhemostatic role in disease pathogenesis. Sci World J 2014;2014:781857. doi:10.1155/2014/781857. PMID: 24729754.
  • Koupenova M, Clancy L, Corkrey HA, Freedman JE. Circulating platelets as mediators of immunity, inflammation, and thrombosis. Circ Res 2018;122(2):337–351. doi:10.1161/CIRCRESAHA.117.310795. PMCID: PMC5777300.
  • Xu XR, Zhang D, Oswald BE, Carrim N, Wang X, Hou Y, Zhang Q, Lavalle C, McKeown T, Marshall AH, et al. Platelets are versatile cells: new discoveries in hemostasis, thrombosis, immune responses, tumor metastasis and beyond. Crit Rev Clin Lab Sci 2016;53(6):409–430. doi:10.1080/10408363.2016.1200008. PMID: 27282765.
  • Estevez B,X. New concepts and mechanisms of platelet activation signalling. Physiology (Bethesda) 2017 ;32(2):162–177. doi:10.1152/physiol.00020.2016. PMID: 28228483.
  • Holinstat M. Normal platelet function. Cancer Metastasis Rev 2017;36(2):195–198. doi:10.1007/s10555-017-9677-x. PMID: 28667366.
  • Schwarz UR, Ulrich Walter U, Eigenthaler M. Taming platelets with cyclic nucleotides. Biochem Pharm 2001;62:1153–1161. doi:10.1016/S0006-2952(01)00760-2. PMID: 11705448.
  • Yun S-H, Sim E-H, Goh R-Y, Park J-I, Han J-Y. Platelet activation: the mechanisms and potential biomarkers. Biomed Res Int 2016;2016:9060143. doi:10.1155/2016/9060143. PMID: 27403440.
  • Freedman JE, Keaney JF Jr. Vitamin E inhibition of platelet aggregation is independent of antioxidant activity. J Nutr 2001;131(2):374S–7S. doi:10.1093/jn/131.2.374S. PMID: 11160564.
  • Freedman JE, Farhat JH, Loscalzo J, Keaney JF. Αlpha-tocopherol inhibits aggregation of human platelets by a protein kinase C-dependent mechanism. Circulation 1996;94:2434–2440. doi:10.1161/01.CIR.94.10.2434.
  • Mabile L, Bruckdorfer KR, Rice-Evans C. Moderate supplementation with natural alpha-tocopherol decreases platelet aggregation and low-density lipoprotein oxidation. Atherosclerosis 1999;1:177–185. doi:10.1016/S0021-9150(99)00169-0. PMID: 10525139.
  • Pignatelli P, Pulcinelli FM, Lenti L, Gazzaniga PP, Violi F. Vitamin E inhibits collagen-induced platelet activation by blunting hydrogen peroxide. Arterioscler Thromb Vasc Biol 1999;19:2542–2547. doi:10.1016/S0021-9150(99)00169-0. PMID: 10521385.
  • Li D, Saldeen T, Romeo F, Mehta JL. Different isoforms of tocopherols enhance nitric oxide synthase phosphorylation and inhibit human platelet aggregation and peroxidation: implications in therapy with vitamin E. J Cardiovasc Pharmacol Ther 2001;6:155–161. doi:10.1177/107424840100600207. PMID: 11509922.
  • Kobzar G, Mardla V, Samel N. Effects of α-tocopherol, L-arginine, and quercetin on the aggregation of human platelets. Nutr Res 2005;25:569–575. doi:10.1016/j.nutres.2005.04.004.
  • Kobzar G, Mardla V, Rätsep I, Samel N. Effect of vitamin B6 vitamers on platelet aggregation. Platelets 2009;20:120–124. doi:10.1080/09537100802687674. PMID: 19235054.
  • Chang SJ, Chang CN, Chen CW. Occupancy of glycoprotein IIb/IIIa by B-6 vitamers inhibits human platelet aggregation. J Nutr 2002;132:3603–3606. doi:10.1093/jn/132.12.3603. PMID: 12468595.
  • Toliopoulos IK, Simos YV, Daskalou TA, Verginadis II, Evangelou AM, Karkabounas SC. Inhibition of platelet aggregation and immunomodulation of NK lymphocytes by administration of ascorbic acid. Indian J Exp Biol 2011;49(12):904–908. PMID: 22403863.
  • Moraes LA, Swales KE, Wray JA, Damazo A, Gibbins JM, Warner TD, Bishop-Bailey D. Nongenomic signaling of the retinoid X receptor through binding and inhibiting Gq in human platelets. Blood 2007;109:3741–3744. doi:10.1182/blood-2006-05-022566. PMID: 17213293.
  • Unsworth AJ, Flora GD, Sasikumar P, Bye AP, Sage T, Kriek N, Crescente M, Gibbins JM. RXR Ligands negatively regulate thrombosis and hemostasis. Arterioscler Thromb Vasc Biol 2017;37(5):812–822. doi:10.1161/ATVBAHA.117.309207. PMID: 28254816.
  • Endo Y, Mamiya S, Miura AB. Effects of riboflavin-2ʹ, 3ʹ, 4ʹ, 5ʹ-tetrabutyrate on platelet function and plasma lipids. Jpn J Med 1985;24:13–18. doi:10.2169/internalmedicine1962.24.13. PMID: 3999460.
  • Calzada C, Bruckdorfer KR, Rice-Evans CA. The influence of antioxidant nutrients on platelet function in healthy volunteers. Atherosclerosis 1997;128:97–105. doi:10.1016/S0021-9150(96)05974-6. PMID: 9051202.
  • Williams JC, Forster LA, Tull SP, Wong M, Bevan RJ, Ferns GA. Dietary vitamin E supplementation inhibits thrombin-induced platelet aggregation, but not monocyte adhesiveness in patients with hypercholesterolemia. Int J Exp Pathol 1997;78:259–266. doi:10.1046/j. PMID: 9505937.
  • Morinobu T, Ban R, Yoshikawa S, Murata T, Tamai H. The safety of high-dose vitamin E supplementation in healthy Japanese male adults. J Nutr Sci Vitaminol 2002;48:6. doi:10.3177/jnsv.48.6. PMID: 12026191.
  • Dereska NH, McLemore EC, Tessier DJ, Bash DS, Brophy CM. Short-term, moderate dosage Vitamin E supplementation may have no effect on platelet aggregation, coagulation profile, and bleeding time in healthy individuals. J Surg Res 2006;132:121–129. doi:10.1016/j.jss.2005.09.031. PMID: 16337968.
  • Gan YL, Fu JY, Lai OM, Chew BH, Yuen KH, Teng KT, Nesaretnam K, Selvaduray KR, Meganathan P. Effect of palm-based tocotrienols and tocopherol mixture supplementation on platelet aggregation in subjects with metabolic syndrome: a randomized controlled trial. Sci Rep 2017;7(1):11542–11552. doi:10.1038/s41598-017-11813-w. PMID: 28912593.
  • Singh I, Turner AH, Sinclair AJ, Li D, Hawley JA. Effects of gamma-tocopherol supplementation on thrombotic risk factors. Asia Pac J Clin Nutr 2007;16(3):422–428. doi:10.6133/apjcn.2007.16.3.05. PMID: 17704022.
  • Liu M, Wallmon A, Olsson-Mortlock C, Wallin R, Saldeen T. Mixed tocopherols inhibit platelet aggregation in humans: potential mechanisms. Am J Clin Nutr 2003;77:700–706. doi:10.1093/ajcn/77.3.700. PMID: 12600864.
  • Qureshi AA, Karpen CW, Qureshi N, Papasian CJ, Morrison DC, Folts JD. Tocotrienols-induced inhibition of platelet thrombus formation and platelet aggregation in stenosed canine coronary arteries. Lipids Health Dis 2011;10:58–71. doi:10.1186/1476-511X-10-58. PMID: 21489303.
  • Kim JE1, Han M, Hanl KS, Kim HK. Vitamin E inhibition on platelet procoagulant activity: involvement of aminophospholipid translocase activity. Thromb Res 2011;127(5):435–442. doi:10.1016/j.thromres.2011.01.007. PMID: 21296386.
  • Harrington MG, Elnageh N. A possible mechanism for the inhibition of blood platelet aggregation by pyridoxal-5ʹ-phosphate. Biochem Soc Trans 1996;24(1):76S. doi:10.1042/bst024076s. PMID: 8674755.
  • Srivastava KC. Ascorbic acid enhances the formation of prostaglandin E1 in washed human platelets and prostacyclin in rat aortic rings. Prostaglandins Leokot Med 1985;18:227–233. doi:10.1016/0262-1746(85)90022-8. PMID: 3925463.
  • Olas B, Wachowicz B. Resveratrol and vitamin C as antioxidants in blood platelets. Thromb Res 2002;106:143–148. doi:10.1016/S0049-3848(02)00101-9. PMID: 12182914.
  • Saremi A, Arora R. Vitamin E and cardiovascular disease. Am J Ther 2010;17(3):e56–65. doi:10.1097/MJT.0b013e31819cdc9a. PMID: 19451807.
  • Vardi M, Levy NS, Levy AP. Vitamin E in the prevention of cardiovascular disease: the importance of proper patient selection. J Lipid Res 2013;54(9):2307–2314. doi:10.1194/jlr.R026641. PMID: 23505320.
  • Loffredo L, Perri L, Di Castelnuovo A, Iacoviello L, De Gaetano G, Violi F. Supplementation with vitamin E alone is associated with reduced myocardial infarction: a meta-analysis. Nutr Metab Cardiovasc Dis 2015;25(4):354–363. doi:10.1016/j.numecd.2015.01.008. PMID: 25779938.
  • Schwingshackl L, Boeing H, Stelmach-Mardas M, Gottschald M, Dietrich S, Hoffmann G, Chaimani A. Dietary supplements and risk of cause-specific death, cardiovascular disease, and cancer: A systematic review and meta-analysis of primary prevention trials. Adv Nutr 2017 17;8(1):27–39. doi:10.3945/an.116.013516. PMID: 28096125.
  • Cordero Z, Drogan D, Weikert C, Boeing H. Vitamin E and risk of cardiovascular diseases: a review of epidemiologic and clinical trial studies. Crit Rev Food Sci Nutr 2010;50(5):420–440. doi:10.1080/10408390802304230. PMID: 20373188.
  • Subbarao K, Kakkar VV, Ganguly P. Binding of pyridoxal phosphate to human platelets: its effect on platelet function. Thromb Res 1978;13:1017–1029. doi:10.1016/0049-3848(78)90230-X. PMID: 749259.
  • Zahavi M, Zahavi J, Kakkar VV. Effect of adenyl-cyclase activators, phosphodiesterase inhibitors and pyridoxal-5-phosphate on platelet aggregation and adenosine-3ʹ-5ʹ-cyclic monophosphate accumulation. Thromb Haemost 1984 31;52(2):205–209. doi:10.1016/0024-3205(84)90167-X. PMID: 6090838.
  • Krishnamurthi S, Westwick J, Kakkar VV. Effect of pyridoxal 5ʹ-phosphate (PALP) on human platelet aggregation, dense granule release, and thromboxane B2 generation – role of Schiff base formation. Thromb Haemost 1982;48:136–141. doi:10.1055/s-0038-1657242. PMID: 6891107.
  • Kobzar G, Mardla V. Inhibition of platelet aggregation by pyridoxine. Nutr Res 2002;22:997–1001. doi:10.1016/S0271-5317(02)00414-1.
  • Fasella P. Pyridoxal phosphate. Annu Rev Biochem 1967;36:185–210. doi:10.1146/annurev.bi.36.070167.001153. PMID: 18257720.
  • Friso S, Girelli D, Martinelli N, Olivieri O, Lotto V, Bozzini C, Pizzolo F, Faccini G, Beltrame F, Corrocher R. Low plasma vitamin B-6 concentrations and modulation of coronary artery disease risk. Am J Clin Nutr 2004;79:992–998. doi:10.1093/ajcn/79.6.992. PMID: 15159228.
  • Lin PT, Cheng CH, Liaw YP, Lee BJ, Lee TW, Huang YC. Low pyridoxal 5ʹ-phosphate is associated with increased risk of coronary artery disease. Nutrition 2006;22:1146–1151. doi:10.1016/j.nut.2006.08.013. PMID: 17045461.
  • Cheng CH, Lin PT, Liaw YP, Ho CC, Tsai TP, Chou MC, Huang YC. Plasma pyridoxal 5ʹ-phosphate and high-sensitivity C-reactive protein are independently associated with an increased risk of coronary artery disease. Nutrition 2008;24:239–244. doi:10.1016/j.nut.2007.12.003. PMID: 18312786.
  • Lee BJ, Yen CH, Hsu HC, Lin JY, Hsia S, Lin PT. A significant correlation between the plasma levels of coenzyme Q10 and vitamin B-6 and a reduced risk of coronary artery disease. Nutr Res 2012;32(10):751–756. doi:10.1016/j.nutres.2012.09.003. PMID: 23146771.
  • Ulvik A, Pedersen ER, Svingen GF, McCann A, Midttun Ø, Nygård O, Ueland PM. Vitamin B-6 catabolism and long-term mortality risk in patients with coronary artery disease. Am J Clin Nutr 2016;103(6):1417–1425. doi:10.3945/ajcn.115.126342. PMID: 27169836.
  • Palareti G, Salardi S, Piazzi S, Legnani C, Poggi M, Grauso F, Caniato A, Coccheri S, Cacciari E. Blood coagulation changes in homocystinuria: effects of pyridoxine and other specific therapy. J Pediatr 1986;109:1001–1006. doi:10.1016/S0022-3476(86)80284-0. PMID: 3783325.
  • Schoene NW, Chanmugam P, Reinolds RD. Effect of oral vitamin B6 supplementation on in vitro platelet aggregation. Am J Clin Nutr 1986;43:825–830. doi:10.1093/ajcn/43.5.825. PMID: 3706190.
  • Van Wyk V, Luus HG, Heyns AP. The in vivo effect in humans of pyridoxal-5ʹ-phosphate on platelet function and blood coagulation. Thromb Res 1992;66:657–668. doi:10.1016/0049-3848(92)90042-9. PMID: 1519226.
  • Sernet A, Aybak M, Ulak G, Guzel C, Denli O. Effect of oral pyridoxine hydrochloride supplementation on in vitro platelet sensitivity to different agonists. Arzneiw-Forsching 1995;45:19–21. PMID: 7893263.
  • Levine M, Padayatty SJ, Espey MG. Vitamin C: a concentration function approach yields pharmacology and therapeutic discoveries. Adv Nutr 2011;2:78–88. doi:10.3945/an.110.000109. PMID: 22332036.
  • Padayatty SJ, Levine M. Vitamin C: the known and the unknown and Goldilocks. Oral Dis 2016;22:463–493. doi:10.1111/odi.12446. PMID: 26808119.
  • Pignatelli P, Sanguigni V, Lo PSG, Coco E, Lenti L, Violi F. Vitamin C inhibits platelet expression of CD40 ligand. Free Radic Biol Med 2005;38:1662–1666. doi:10.1016/j.freeradbiomed.2005.02.032. PMID: 15917194.
  • Raghavan SA, Sharma P, Dikshit M. Role of ascorbic acid in the modulation of inhibition of platelet aggregation by polymorphonuclear leukocytes. Thromb Res 2003;110:117–126. doi:10.1016/S0049-3848(03)00312-8. PMID: 12893026.
  • Owu DU, Nwokocha CR, Ikpi DE, Ogar EI. Effect of vitamin C supplementation on platelet aggregation and serum electrolytes levels in streptozotocin-induced diabetes mellitus in rats. Niger J Physiol Sci 2016 30;31(1):55–61. PMID: 27574765.
  • Ye Z, Song H. Antioxidant vitamins intake and the risk of coronary heart disease: meta-analysis of cohort studies. Eur J Cardiovasc Prev Rehabil 2008;15:26–34. doi:10.1097/HJR.0b013e3282f11f95. PMID: 18277182.
  • Wilkinson IB, Megson IL, MacCallum H, Sogo N, Cockcroft JR, Webb DJ. Oral vitamin C reduces arterial stiffness and platelet aggregation in humans. J Cardiovasc Pharmacol 1999;34:690–693. doi:10.1097/00005344-199911000-00010. PMID: 10547085.
  • Schindler TH, Lewandowski E, Olschewski M, Hasler K, Solzbach U, Just H. Effect of vitamin C on platelet aggregation in smokers and nonsmokers. Med Klin (Munich) 2002;97:263–269. PMID: 12078386.
  • Kubota Y, Iso H, Date C, Kikuchi S, Watanabe Y, Wada Y, Inaba Y, Tamakoshi A. Dietary intakes of antioxidant vitamins and mortality from cardiovascular disease: the Japan Collaborative Cohort Study (JACC) study. Stroke 2011;42(6):1665–1672. doi:10.1161/STROKEAHA.110.601526. PMID: 21512181.
  • Stepaniak U, Micek A, Grosso G, Stefler D, Topor-Madry R, Kubinova R, Malyutina S, Peasey A, Pikhart H, Nikitin Y, et al. Antioxidant vitamin intake and mortality in three Central and Eastern European urban populations: the HAPIEE study. Eur J Nutr 2016;55(2):547–560. doi:10.1007/s00394-015-0871-8. PMID: 25762013.
  • Knekt P, Ritz J, Pereira MA, O’Reilly EJ, Augustsson K, Fraser GE, Goldbourt U, Heitmann BL, Hallmans G, Liu S, et al. Antioxidant vitamins and coronary heart disease risk: a pooled analysis of 9 cohorts. 1: Am J Clin Nutr 2004;80:1508–1520. doi:10.1093/ajcn/80.6.1508. PMID: 15585762.
  • Al-Khudairy L, Flowers N, Wheelhouse R, Ghannam O, Hartley L, Stranges S, Rees K. Vitamin C supplementation for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 2017;3:CD011114. doi:10.1002/14651858.CD011114.pub2. PMID: 28301692.
  • Micronutrient Information Center, Linus Pauling Institute. Oregon State University. Vitamin A. Corvallis, Oregon 2014 [cited 2019 Feb 8]. Available from: https://lpi.oregonstate.edu/mic/vitamins/vitamin-A
  • Tanoury ZA, Piskunov A, Rochette-Egly C. Vitamin A and retinoid signaling: genomic and nongenomic effects. J Lipid Res 2013;54(7):1761–1775. doi:10.1194/jlr.R030833. PMID: 23440512.
  • Lüsebrink E, Warm V, Pircher J, Ehrlich A, Zhang Z, Strecker J, Chambon P, Massberg S, Schulz C, Petzold T. Role of RXRβ in platelet function and arterial thrombosis. J Thromb Haemost Forthcoming. doi:10.1111/jth.14531. PMID: 31172692.
  • Buijsse B, Feskens EJ, Kwape L, Kok FJ, Kromhout D. Both alpha- and beta-carotene, but not tocopherols and vitamin C, are inversely related to 15-year cardiovascular mortality in Dutch elderly men. J Nutr 2008;138(2):344–350. doi:10.1093/jn/138.2.344. PMID: 18203902.
  • Claudel T, Leibowitz MD, Fiévet C, Tailleux A, Wagner B, Repa JJ, Torpier G, Lobaccaro J-M, Paterniti JR, Mangelsdorf DJ. Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor. Proc Natl Aca Sci 2001;98:2610–2615. doi:10.1073/pnas.041609298. PMID:11226287.
  • Micronutrient Information Center, Linus Pauling Institute. Oregon State University. Vitamin D. Corvallis, Oregon 2014 [cited 2019 Feb 8]. Available from: https://lpi.oregonstate.edu/mic/vitamins/vitamin-D
  • Schwingshackl L, Boeing H, Stelmach-Mardas M, Gottschald M, Dietrich S, Hoffmann G, Chaimani A. Dietary supplements and risk of cause-specific death, cardiovascular disease, and cancer: A systematic review and meta-analysis of primary prevention trials. Adv Nutr 2017;8(1):27–39. doi:10.3945/an.116.013516. PMID: 28096125.
  • Silvagno F, De Vivo E, Attanasio A, Gallo V, Mazzucco G, Pescarmona G. Mitochondrial localization of vitamin D receptor in human platelets and differentiated megakaryocytes. PLoS One 2010;5(1):e8670. doi:10.1371/journal.pone.0008670. PMID: 20107497.
  • Agwu DE, Holub BJ. Evidence for 1,25-dihydroxycholecalciferol (1,25-(OH)2D3) as a proaggregating agent in rat and human platelets. Can J Physiol Pharmacol 1983;61(8):954–955. doi:10.1139/y83-143. PMID: 6688753.
  • Stach K, Kälsch AI, Nguyen XD, Elmas E, Kralev S, Lang S, Weiss C, Borggrefe M, Kälsch T. 1α,25-dihydroxyvitamin D3 attenuates platelet activation and the expression of VCAM-1 and MT1-MMP in human endothelial cells. Cardiology 2011;118(2):107–115. doi:10.1159/000327547. PMID: 21546774.
  • Sultan M, Twito O, Tohami T, Ramati E, Neumark E, Rashid G. Vitamin D diminishes the high platelet aggregation of type 2 diabetes mellitus patients. Platelets 2019;30(1):120–125. doi:10.1080/09537104.2017.1386298. PMID:29313404.
  • Verdoia M, Pergolini P, Rolla R, Sartori C1, Nardin M, Schaffer A, Barbieri L, Daffara V, Marino P, Bellomo G, et al. Vitamin D levels and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor. Platelets 2016;27(6):576–582. doi:10.3109/09537104.2016.1149159. PMID: 27540959.
  • Knežević Praveček M, Vuković-Arar Ž, Miškić B, Hadžibegović I. Vitamin D deficiency in acute coronary syndrome - clinically relevant or incidental finding? Cent Eur J Public Health 2017;25(3):185–190. doi:10.21101/cejph.a4577. PMID: 29022676.
  • Al-Khalidi B, Kimball SM, Rotondi MA, Ardern CI. Standardized serum 25-hydroxyvitamin D concentrations are inversely associated with cardiometabolic disease in U.S. adults: a cross-sectional analysis of NHANES, 2001-2010. Nutr J 2017;16(1):16–28. doi:10.1186/s12937-017-0237-6. PMID: 28241878.
  • Muscogiuri G, Annweiler C, Duval G, Karras S, Tirabassi G, Salvio G, Balercia G, Kimball S, Kotsa K, Mascitelli L, et al. Vitamin D and cardiovascular disease: from atherosclerosis to myocardial infarction and stroke. Int J Cardiol 2017;230:577–584. doi:10.1016/j.ijcard.2016.12.053. PMID: 28043680.
  • Zhang R, Li B, Gao X, Tian R, Pan Y, Jiang Y, Gu H, Wang Y, Wang Y, Liu G. Serum 25-hydroxyvitamin D and the risk of cardiovascular disease: dose-response meta-analysis of prospective studies. Am J Clin Nutr 2017;105(4):810–819. doi:10.3945/ajcn.116.140392. PMID: 28251933.
  • Yu C, Xue H, Wang L, Chen Q, Chen X, Zhang Y, Hu G, Ling W. Serum bioavailable and free 25-hydroxyvitamin D levels, but not its total level, are associated with the risk of mortality in patients with coronary artery disease. Circ Res 2018;123(8):996–1007. doi:10.1161/CIRCRESAHA.118.313558. PMID: 30355032.
  • Scragg R, Stewart AW, Waayer D, Lawes CM1, Toop L, Sluyter J, Murphy J, Khaw KT, Camargo CA Jr. Effect of monthly high-dose vitamin D supplementation on cardiovascular disease in the vitamin D assessment study: a randomized clinical trial. JAMA Cardiol 2017;2(6):608–616. doi:10.1001/jamacardio.2017.0175. PMID: 28384800.
  • Aslanabadi N, Jafaripor I, Sadeghi S, Hamishehkar H, Ghaffari S, Toluey M, Azizi H, Entezari-Maleki T. Effect of vitamin D in the prevention of myocardial injury following elective percutaneous coronary intervention: a pilot randomized clinical trial. J Clin Pharmacol 2018;58(2):144–151. doi:10.1002/jcph.989. PMID: 28841229.
  • Micronutrient Information Center, Linus Pauling Institute. Oregon State University. Folate. Corvallis, Oregon 2014 [cited 2019 Feb 8]. Available from: https://lpi.oregonstate.edu/mic/vitamins/folate
  • Romecín P, Atucha NM, Navarro EG, Ortiz MC, Iyú D, Rosado JA, García-Estañ J. Role of homocysteine and folic acid on the altered calcium homeostasis of platelets from rats with biliary cirrhosis. Platelets 2017;28(7):698–705. doi:10.1080/09537104.2016.1265920. PMID: 28150525.
  • Mao X, Xing X, Xu R, Gong Q, He Y, Li S, Wang H, Liu C, Ding X, Na R, et al. Folic acid and vitamins D and B12 correlate with homocysteine in Chinese patients with type-2 diabetes mellitus, hypertension, or cardiovascular disease. Medicine (Baltimore) 2016;95(6):e2652. doi:10.1097/MD.0000000000002652. PMID: 26871790.
  • Ma Y, Peng D, Liu C, Huang C, Luo J. Serum high concentrations of homocysteine and low levels of folic acid and vitamin B12 are significantly correlated with the categories of coronary artery diseases. BMC Cardiovasc Disord 2017;17(1):37. doi:10.1186/s12872-017-0475-8. PMID: 28109191.
  • Zeng R, Xu CH, Xu YN, Wang YL, Wang M. The effect of folate fortification on folic acid-based homocysteine-lowering intervention and stroke risk: a meta-analysis. Public Health Nutr 2015;18(8):1514–1521. doi:10.1017/S1368980014002134. PMID: 25323814.
  • Li Y, Huang T, Zheng Y, Muka T, Troup J, Hu FB. Folic acid supplementation and the risk of cardiovascular diseases: A meta-analysis of randomized controlled trials. J Am Heart Assoc 2016;5(8):e003768. doi:10.1161/JAHA.116.003768. PMID: 27528407.
  • Micronutrient Information Center, Linus Pauling Institute. Oregon State University. Riboflavin. Corvallis, Oregon 2014 [cited 2019 Feb 8]. Available from: https://lpi.oregonstate.edu/mic/vitamins/riboflavin
  • Higashi O, Ishigaki W, Hashimoto T. Effects of riboflavin-2ʹ,3ʹ,4ʹ,5ʹ-tetrabutyrate and flavin adenine dinucleotide on the platelet aggregation induced by hydrogen peroxide. Tohoku J Exp Med 1978;124:323–329. doi:10.1620/tjem.124.323. PMID: 663930. PMID: 24306059.
  • Shimada K, Takahashi W, Watanabe A, Matsuno K, Higashi O. Further studies on the effects of flavine adenine dinucleotide on the platelet functions. Tohoku J Exp Med 1983;140:81–88. doi:10.1620/tjem.140.81. PMID: 6408764.
  • Fuentes E, Badimon L, Caballero J, Padró T, Vilahur G, Alarcón M, Pérez P, Palomo I. Protective mechanisms of adenosine 5ʹ-monophosphate in platelet activation and thrombus formation. Thromb Haemost 2014;111(3):491–507. doi:10.1160/TH13-05-0386.
  • Mack CP, Hultquist DE, Shlafer M. Myocardial flavin reductase and riboflavin: a potential role in decreasing reoxygenation injury. Biochem Biophys Res Commun 1995;212(1):35–40. doi:10.1006/bbrc.1995.1932. PMID: 7612015.
  • Betz AL, Ren XD, Ennis SR, Hultquist DE. Riboflavin reduces edema in focal cerebral ischemia. Acta Neurochir Suppl (Wien) 1994;60:314–317. doi:10.1007/978-3-7091-9334-1_84. PMID: 7976577.
  • Ubbink JB, Serfontein WJ, Becker PJ, de Villiers LS. Effect of different levels of oral pyridoxine supplementation on plasma pyridoxal-5ʹ-phosphate and pyridoxal levels and urinary vitamin B-6 excretion. Am J Clin Nutr 1987;46:78–85. doi:10.1093/ajcn/46.1.78. PMID: 3604972.
  • Mardla V, Kobzar G, Samel N. Potentiation of antiaggregating effect of prostaglandins by α-tocopherol and quercetin. Platelets 2004;15:319– 324. doi:10.1080/09537100410001710263. PMID: 15370103.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.